Managing Cardiometabolic Disease During and After a Pandemic

Activity Preview

The COVID-19 pandemic has serious implications for individuals with cardiometabolic diseases. Not only are they at a high risk for COVID-19 complications, but many will need help managing their condition as stay-at-home orders disrupt routine medical care. In this workshop, find out how you can provide guidance for patients who need assistance now more than ever. Two experts will use four patient cases to share evidence-based care management strategies that you can apply during and after the pandemic.

This session is eligible for general ACPE credit only. If you are looking to earn BCACP recertification credit for this session, please enroll in the 2021 Trending Topics Ambulatory Care Recertification Package. For more information, please visit 2021 Trending Topics Ambulatory Care Recertification Package

Learning Objectives

At the completion of this application-based activity, pharmacists will be able to  

  1. Describe expert consensus recommendations from guidelines applicable to the treatment of patients with cardiometabolic diseases
  2. Select evidence-based pharmacotherapy to reduce atherosclerotic cardiovascular disease (ASCVD) in patients with hypertension and compelling indications
  3. Apply data from cardiovascular outcomes studies evaluating glycemic-lowering medications in patients with type 2 diabetes and heart failure
  4. Formulate patient-centered treatment plans for patients with uncontrolled ASCVD risk factors

Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 2 contact hours of CPE credit (0.2 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-022-H01-P

To obtain credit for completing Managing Cardiometabolic Disease During and After a Pandemic, participants will need to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

Initial release date: March 15, 2021
Expiration date: March 15, 2024 - No credit granted after this date

Development

Managing Cardiometabolic Disease During and After a Pandemic is an activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association. © 2021 American Pharmacists Association

Disclosures

Speaker disclosures will be provided at the time of the seminar and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 

Fee

This learning product is a component of the APhA2021 Virtual Education package. This session is part of the Trending Topics in Ambulatory Care series.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-022-H01-P 0.2 CEUs March 15, 2021 - March 15, 2024